Posted on 7/10/18
Interview with Scott Applebaum, President of Context Therapeutics - Part II
Brought to you by Newmark Knight Frank
Posted on 6/29/18
Interview with Scott Applebaum, President of Context Therapeutics - Part I
Brought to you by Newmark Knight Frank
Posted on 6/19/18
Verrica Pharmaceuticals Closes IPO
WEST CHESTER, Pa., June 19, 2018 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (Nasdaq:VRCA), a pharmaceutical company focused on identifying, developing and commercializing innovative pharmaceutical products for . . .
Posted on 6/18/18
New Study Finds Reusable Bronchoscopes Contaminated and Damaged Even When Proper Cleaning and Disinfection Steps are Taken
Using Single-Use Bronchoscopes Could Significantly Reduce the Risk of Life-threatening Infection Transmission Among PatientsBronchoscopy is one of the most common interventional pulmonology procedures and most practitioners . . .
Posted on 6/17/18
Marinus Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(C)(4)
RADNOR, Pa., June 15, 2018 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS) (the “Company”, “Marinus”), a biopharmaceutical company dedicated to the development of innovative therapeutics to . . .
Posted on 6/14/18
Verrica Pharmaceuticals Goes Public
WEST CHESTER, Pa., June 14, 2018 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (Nasdaq:VRCA), a pharmaceutical company focused on identifying, developing and commercializing innovative pharmaceutical products for . . .
Posted on 6/11/18
HC2 Sells BeneVir Biopharm To Janssen Biotech For $1.04 Billion
HC2 Holdings, Inc. (NYSE:HCHC), a diversified holding company, announced today that it has completed the sale of BeneVir Biopharm, Inc.,
Posted on 6/7/18
PANTHERx Specialty Pharmacy Selected by Ultragenyx to Distribute Crysvita
PANTHERx Specialty Pharmacy, THE Rare Disease Specialty Pharmacy, announced that it has been selected by Ultragenyx Pharmaceutical, Inc. to distribute Crysvita (burosumab-twza), the very first FDA-approved . . .
Posted on 6/6/18
Noble Life Sciences Selects Comprehensive Suite of Preclinical Software Solutions from Instem
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Instem, a leading provider of IT solutions to the global life sciences market, is pleased to announce that Noble Life Sciences, Inc. (Noble) has . . .
Posted on 6/5/18
Madrigal Pharmaceuticals Proposes Public Offering of Common Stock
CONSHOHOCKEN, Pa., June 05, 2018 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (Nasdaq:MDGL), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutic candidates . . .
Posted on 6/5/18
Aclaris Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
WAYNE, Pa., June 04, 2018 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a dermatologist-led biopharmaceutical company focused on identifying, developing, and commercializing innovative and differentiated therapies . . .
Posted on 6/5/18
Optinose Announces Launch of Public Offering of Common Stock
YARDLEY, Pa., June 04, 2018 (GLOBE NEWSWIRE) -- OptiNose, Inc. (NASDAQ:OPTN), announced today that it has filed a registration statement on Form S-1 with the U.S. . . .
Posted on 5/25/18
VWR Named Sole Supplier for Cell and Gene Therapy Catapult
VWR, acquired by Avantor in 2017 as a wholly-owned subsidiary and a leading global provider of product and service solutions to laboratory and production customers, has . . .
Posted on 5/24/18
Recro Pharma Receives Complete Response Letter from the FDA
MALVERN, Penn., May 24, 2018 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for the hospital and other . . .
Posted on 5/24/18
Fibrocell Announces One-for-Five Reverse Stock Split
EXTON, Pa., May 24, 2018 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc. (NASDAQ:FCSC), a gene therapy company focused on transformational autologous cell-based therapies for skin and connective . . .
Posted on 5/18/18
Boston Medical Center Wins ECRI Institute's Award for Pulmonary Care App
ECRI Institute is pleased to announce that Boston Medical Center is the winner of the 2018 Health Devices Achievement Award. The award, now in its 12th . . .
Posted on 5/9/18
PANTHERx Specialty Pharmacy Wins Patient Choice Award
PANTHERx® Specialty Pharmacy, THE Rare Disease Specialty Pharmacy®, has been named the winner of the Specialty Pharmacy Patient Choice Award™ for the non-PBM/payer category. This is . . .
Posted on 5/8/18
Trevena Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
CHESTERBROOK, Pa., May 08, 2018 (GLOBE NEWSWIRE) -- Trevena, Inc. (NASDAQ:TRVN) today announced that the independent Compensation Committee of the Board of Directors of the Company . . .
Posted on 5/4/18
Strongbridge Biopharma plc Announces New Employment Inducement Awards
DUBLIN, Ireland and TREVOSE, Pa., May 03, 2018 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq:SBBP), a global commercial-stage biopharmaceutical company focused on the development and commercialization . . .
Posted on 5/2/18
Aclaris Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
WAYNE, Pa., May 02, 2018 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a dermatologist-led, biopharmaceutical company focused on identifying, developing and commercializing innovative and differentiated therapies . . .
Posted on 5/2/18
Marinus Pharmaceuticals Provides Business Update
RADNOR, Pa., May 02, 2018 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS), a biopharmaceutical company dedicated to the development of innovative therapeutics to treat epilepsy and . . .
Posted on 5/2/18
Onconova Therapeutics Closes $28.75M Offering
NEWTOWN, Pa., May 01, 2018 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing small molecule drug . . .
Posted on 5/2/18
Trevena and Jiangsu Nhwa Pharmaceutical Co. Ltd Announce License Agreement for Oliceridine in China
CHESTERBROOK, Pa. and XUZHOU, China, May 01, 2018 (GLOBE NEWSWIRE) -- Trevena, Inc. (NASDAQ:TRVN) and Jiangsu Nhwa Pharmaceutical Co. Ltd. (Shenzhen Stock Exchange:002262) announced today that . . .
Posted on 4/27/18
Onconova Therapeutics Prices $25.0M Upsized Underwritten Public Offering
NEWTOWN, Pa., April 27, 2018 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing small molecule drug . . .
Posted on 4/27/18
Palmyra Nursing Homes Awarded Five-Stars by Centers for Medicare and Medicaid
The Gardens at Palmyra and The Gardens at Campbelltown, both located in Palmyra, PA, attained The Centers for Medicare and Medicaid Services overall rating of five . . .
Pittsburgh
